TSS:Rfhg 58011.1

Basic information about the TSS

---

TSS ID: rfhg_58011.1 Species: human Chr: chr4		Start: 57023565 End: 57023567 Strand: +
Source datasets	PRJNA401781
Protocol	oligo_capping
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000484821.1:-74 GeneID: 5431 HGNC/MGI_ID: HGNC:9188 UniProt_ID: Nearer transcript ids and distances: ENST00000464918.1:-338

Gene_name: POLR2B Gene_symbol: POLR2B Gene_synonyms: RPB2 Gene_source: HGNC:9188

TATA-Box annotation

---

Distance to TSS:	44670
Nearest PromoterID:	NM_000938
Entrez ID:	5431
Nearest Unigene:	Hs.602757
Nearest Refseq:	NM_000938
Nearest Ensembl:	ENSG00000047315
Gene Name:	POLR2B
Gene Alias:	POL2RB|RPB2|hRPB140
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@POLR2B p2@POLR2B p3@POLR2B p4@POLR2B
Sample		p1@POLR2B	p2@POLR2B	p3@POLR2B	p4@POLR2B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	81.82	7.79	0.97	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.45	7.49	0.20	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	79.48	6.75	1.16	2.31
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	63.83	7.07	0.83	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	67.94	6.30	0.45	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	72.87	6.98	0.97	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	88.02	9.59	2.61	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	93.50	6.78	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.59	3.63	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	42.89	4.06	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	50.13	4.04	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	41.87	3.25	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	41.75	3.71	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	43.75	3.46	2.86	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	40.62	4.39	1.76	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	40.99	2.77	2.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.00	4.80	2.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.96	3.37	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.19	4.27	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	43.63	3.61	2.11	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.10	3.34	2.14	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	40.57	4.83	1.90	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.30	3.88	2.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.74	4.85	2.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.02	3.35	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.20	3.80	3.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.15	4.95	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.57	4.72	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.17	2.26	1.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.79	3.62	1.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.75	2.09	1.67	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.43	3.52	1.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	34.19	3.59	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.70	2.97	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	43.38	4.86	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	37.17	3.83	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	42.51	5.93	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	44.13	2.22	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	44.03	5.67	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.61	3.60	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.64	5.65	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.26	4.54	1.46	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	46.40	5.27	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.78	4.02	1.22	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.97	5.02	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.74	5.35	2.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.75	3.84	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.26	3.87	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.26	4.79	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.22	2.43	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	48.57	4.10	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	50.70	3.11	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	713.60	69.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	47.91	4.26	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.44	2.98	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	163.59	19.30	6.71	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	81.75	3.67	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	53.15	4.86	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	45.28	4.50	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	82.04	7.86	2.20	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	37.37	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.82	1.68	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	94.74	8.76	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	54.36	2.72	3.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	43.86	3.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.95	3.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	565.74	161.64	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	608.11	55.28	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	48.26	1.95	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.59	3.47	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	59.11	5.16	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	87.43	4.64	2.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	71.15	6.19	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	59.93	3.97	3.06	0.31
Adipocyte - breast, donor1	11376-118A8	47.67	2.22	2.22	0.16
Adipocyte - breast, donor2	11327-117E4	54.38	4.33	1.28	0.32
Adipocyte - omental, donor1	11473-119C6	51.02	4.71	2.04	0.25
Adipocyte - omental, donor2	11474-119C7	25.41	3.74	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	36.17	4.02	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	36.37	3.19	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	42.45	4.06	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	25.89	4.17	0.70	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	69.43	7.63	2.15	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	48.64	5.40	2.32	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	51.29	4.74	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	57.61	4.70	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	72.47	10.05	2.09	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	54.87	7.42	2.26	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	53.85	1.07	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	40.62	5.56	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	51.15	8.32	2.50	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	45.46	3.27	1.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	44.83	5.56	2.62	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	46.58	4.57	1.52	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	15.03	1.99	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	6.10	1.08	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.25	1.62	0.90	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.71	1.23	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	73.00	6.52	3.66	0.34
Anulus Pulposus Cell, donor2	11463-119B5	39.43	4.16	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	51.67	4.94	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	52.97	8.25	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	51.71	3.89	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	5.06	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.68	3.30	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	40.94	1.95	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	37.38	2.43	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	50.48	2.97	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	57.63	3.39	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	40.64	2.90	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	5.02	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	64.08	6.10	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	4.09	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	46.44	4.98	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	40.72	5.89	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	53.85	5.67	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	50.52	3.74	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	33.17	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	49.92	4.81	1.16	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	46.83	3.60	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	10.62	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	49.57	3.95	0.69	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	56.79	4.37	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	55.40	6.83	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	64.20	4.85	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	50.73	4.56	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.46	3.85	1.07	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	38.46	2.06	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.64	2.35	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	44.37	1.93	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	45.66	2.85	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	34.51	5.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	56.60	4.22	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	53.40	2.54	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	62.91	5.35	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	36.85	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	34.95	6.47	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	51.65	4.23	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	42.92	3.77	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	43.46	3.78	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	44.92	4.92	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	49.10	1.07	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	43.92	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	47.38	2.92	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	53.79	4.60	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	50.34	4.07	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.83	5.57	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	40.09	4.59	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	59.27	3.35	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.23	1.77	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	51.51	3.88	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	40.78	3.71	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.62	2.54	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	26.16	3.44	1.23	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.67	1.03	0.68	0.00
Astrocyte - cerebellum, donor3	11661-122F5	10.70	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	93.77	11.15	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	92.37	6.31	1.62	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	83.08	9.10	1.64	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	141.18	11.81	4.01	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	151.59	10.40	3.26	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	150.44	12.63	3.87	0.46
Basophils, donor1	12241-129G9	27.46	1.83	1.05	0.52
Basophils, donor2	12242-129H1	124.11	10.46	1.08	0.00
Basophils, donor3	12243-129H2	36.16	3.97	1.03	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	7.11	0.65	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	52.72	3.77	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	16.22	1.87	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	20.96	2.53	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	51.46	1.80	2.34	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	89.04	5.36	3.71	2.37
Burkitt's lymphoma cell line:RAJI	10476-106I8	161.64	17.23	6.99	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	92.73	9.27	2.88	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	42.27	3.94	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	49.56	2.78	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	39.30	3.51	0.88	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	96.52	4.81	3.68	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	89.84	4.17	3.41	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	92.38	8.55	1.97	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	106.82	4.91	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	96.56	4.83	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	142.85	4.50	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	64.11	2.34	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	61.27	1.38	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	93.72	3.22	0.25	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	59.72	0.98	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	63.03	2.85	0.36	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	108.16	4.13	0.87	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	57.83	2.58	1.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	87.65	3.17	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	77.66	3.33	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	79.13	3.27	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	88.80	1.80	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	113.26	3.33	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	67.49	2.52	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	75.78	2.71	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	78.13	2.62	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	103.83	5.11	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	92.46	5.93	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	109.41	3.37	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.58	0.55	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	66.58	1.41	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	75.90	1.75	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	68.35	2.62	0.87	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	90.32	3.72	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	107.99	6.04	0.22	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	45.86	3.28	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	65.60	3.01	0.70	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	80.27	2.32	0.46	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	86.75	2.83	1.96	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	68.37	3.93	1.39	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	78.41	4.77	1.30	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	87.36	4.83	2.02	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	82.61	3.32	1.22	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	113.05	4.68	2.01	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	71.19	4.34	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	84.97	3.73	1.76	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	94.11	4.63	1.47	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	148.36	8.13	2.03	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	137.63	5.42	4.07	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	162.59	6.21	6.21	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	193.49	9.59	4.26	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	180.65	9.65	9.65	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	144.60	7.72	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	156.09	8.63	3.92	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	160.83	9.23	3.95	1.32
CD19+ B Cells, donor1	11544-120B5	101.09	6.58	3.29	2.47
CD19+ B Cells, donor2	11624-122B4	114.62	7.25	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	121.16	4.54	2.52	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	181.42	10.51	8.49	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	133.83	5.19	4.39	0.80
CD34+ Progenitors, donor1	11545-120B6	54.22	8.03	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	96.07	7.30	1.12	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	91.31	7.89	3.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	120.63	11.73	4.06	1.13
CD4+ T Cells, donor1	11225-116C1	105.33	8.21	5.00	6.07
CD4+ T Cells, donor2	11306-117C1	77.77	6.74	2.45	3.06
CD4+ T Cells, donor3	11382-118B5	79.60	4.57	3.05	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	139.10	10.72	3.83	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	135.88	10.33	5.17	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	140.86	7.76	6.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	107.62	8.06	2.84	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	118.69	7.73	3.51	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	121.96	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	107.66	10.98	5.49	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	85.75	6.78	2.71	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	84.63	6.13	2.26	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	102.21	6.28	2.69	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	109.01	8.04	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	135.95	6.16	3.96	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	126.91	8.01	8.43	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	92.46	8.10	3.12	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	92.22	6.68	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	137.60	8.70	4.08	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	175.79	12.86	5.90	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	116.56	12.55	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	150.01	9.46	5.75	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	99.43	9.31	2.82	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	107.81	6.51	3.57	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	90.00	7.08	5.06	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	112.65	9.96	4.33	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	157.33	15.69	4.36	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	192.01	12.87	6.43	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	181.87	10.16	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	135.39	9.77	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	213.51	19.11	4.71	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	253.98	24.29	3.93	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	198.66	16.94	6.16	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	200.55	13.97	5.37	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	155.12	16.62	6.92	1.38
CD8+ T Cells, donor1	11226-116C2	91.02	10.48	2.95	2.95
CD8+ T Cells, donor2	11307-117C2	89.73	6.38	2.25	5.63
CD8+ T Cells, donor3	11383-118B6	90.90	8.33	1.77	4.29
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	62.39	2.98	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	67.34	6.23	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	74.14	5.75	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	93.07	9.01	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	55.92	4.08	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	59.35	5.23	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	75.18	4.13	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	73.17	2.90	2.37	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	64.26	4.69	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	76.68	6.34	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	65.65	2.91	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.07	5.86	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	59.10	2.63	0.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.93	5.47	0.46	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	5.22	1.49	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	47.18	4.68	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	44.02	5.47	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	49.26	2.12	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	91.27	7.29	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	77.20	4.92	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	73.41	5.77	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	72.29	7.27	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	53.60	7.09	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	67.32	6.81	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	75.48	3.21	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	85.33	2.80	2.10	5.60
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	82.14	5.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	49.35	7.31	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	42.99	1.98	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	53.35	5.68	2.42	0.32
Chondrocyte - de diff, donor1	11261-116G1	52.69	4.51	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	31.27	3.55	2.13	0.36
Chondrocyte - de diff, donor3	11410-118E6	31.97	2.28	1.14	0.00
Chondrocyte - re diff, donor2	11339-117F7	94.00	14.32	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	20.22	2.02	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	110.28	12.28	4.25	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	79.31	7.27	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	76.99	9.38	2.57	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	56.76	13.39	5.23	0.18
Corneal Epithelial Cells, donor1	11526-119I5	5.05	0.00	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.59	0.51	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	79.74	4.95	1.65	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	87.37	2.52	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	49.24	2.38	0.54	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	113.08	15.03	2.73	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	116.86	15.02	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	138.41	24.20	2.42	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	55.53	5.50	2.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	28.75	1.17	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	59.95	1.98	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	36.17	2.75	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	33.45	3.20	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	63.05	5.65	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	47.86	2.98	0.88	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	53.42	4.43	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	62.37	5.48	1.52	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	67.09	5.07	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	39.52	2.08	1.49	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	47.38	4.17	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.43	1.42	0.71	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	117.24	6.00	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	30.92	1.05	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	140.90	9.57	2.48	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	65.18	3.69	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.26	2.69	1.34	0.00
Endothelial Cells - Vein, donor1	11267-116G7	47.78	3.41	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	37.72	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	39.09	3.14	1.41	0.16
Eosinophils, donor1	12244-129H3	45.74	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	102.32	8.25	0.00	0.00
Eosinophils, donor3	12246-129H5	57.07	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	0.24	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	52.96	7.39	2.87	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.47	3.18	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.13	2.06	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	65.01	6.43	1.33	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	118.32	19.11	2.73	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	40.71	4.54	0.95	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	118.57	13.44	3.43	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.48	4.32	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	42.19	5.90	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	25.01	2.27	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.45	2.52	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	75.17	8.49	3.03	0.30
Fibroblast - Cardiac, donor5	11456-119A7	79.19	7.74	2.03	0.13
Fibroblast - Cardiac, donor6	11460-119B2	75.49	5.15	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.73	2.28	2.01	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	33.22	6.04	2.16	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	111.32	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	17.07	1.61	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	77.34	8.31	3.39	0.34
Fibroblast - Dermal, donor1	11269-116G9	48.83	5.87	1.17	0.23
Fibroblast - Dermal, donor2	11346-117G5	46.22	2.83	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	51.98	6.29	2.06	0.00
Fibroblast - Dermal, donor4	11450-119A1	78.91	6.56	1.92	0.00
Fibroblast - Dermal, donor5	11454-119A5	84.26	6.80	0.70	0.00
Fibroblast - Dermal, donor6	11458-119A9	113.70	9.58	1.79	0.00
Fibroblast - Gingival, donor1	11237-116D4	82.04	8.95	3.12	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	4.19	2.88	0.00
Fibroblast - Gingival, donor2	11318-117D4	80.26	6.19	1.05	0.13
Fibroblast - Gingival, donor3	11394-118C8	56.66	4.54	2.61	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	4.16	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	36.47	4.41	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	65.16	5.30	1.40	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	64.37	3.79	1.89	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.82	1.41	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	53.38	3.36	2.49	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	62.86	6.14	0.95	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	64.39	5.70	0.77	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.84	5.14	2.35	0.29
Fibroblast - Lung, donor1	11270-116H1	19.03	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	82.07	7.46	7.46	0.00
Fibroblast - Lung, donor3	11419-118F6	47.06	5.06	1.27	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.04	1.12	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	24.76	2.44	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	94.85	7.37	1.94	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	93.13	5.76	2.58	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	86.29	8.87	2.45	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.94	2.67	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.96	2.70	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.25	1.51	0.93	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	77.04	6.63	2.32	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.86	1.02	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	42.30	1.98	1.98	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	155.98	13.69	4.37	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	49.20	7.99	4.09	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	64.25	5.72	2.17	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	107.71	11.13	1.50	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	82.47	9.61	3.13	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	124.01	17.72	4.56	0.51
Fibroblast - skin normal, donor1	11553-120C5	54.64	8.20	2.13	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	124.31	16.84	6.02	0.60
Fibroblast - skin normal, donor2	11561-120D4	81.37	7.33	3.42	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	173.79	19.65	5.14	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	66.61	8.86	3.73	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	98.64	12.31	3.76	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	118.56	13.79	4.60	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	91.50	9.16	2.77	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	74.56	6.07	1.86	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	44.07	3.29	0.94	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	686.95	88.64	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	60.14	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	60.50	4.33	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	54.91	5.20	1.04	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.83	5.11	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	51.29	6.89	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	97.62	7.66	3.19	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	164.03	14.83	5.13	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	110.58	9.10	3.03	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	93.39	11.19	2.28	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	90.35	10.90	3.57	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	90.93	7.40	1.85	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	96.54	12.39	2.61	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	109.23	9.73	3.98	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	69.39	8.76	1.27	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.72	8.87	1.11	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.81	7.25	2.15	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	60.34	6.32	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	61.88	6.64	0.83	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	82.74	5.29	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	65.49	6.16	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	57.92	5.48	1.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	48.09	3.93	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	57.62	4.14	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	62.15	8.11	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	48.26	4.69	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	69.36	4.84	2.42	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	74.98	8.31	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	94.79	10.73	2.04	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.85	9.99	2.91	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	98.54	11.10	3.24	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	61.63	7.86	1.66	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	89.27	7.49	1.75	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.09	8.17	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	81.70	6.60	1.65	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	58.22	11.18	1.38	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	62.04	6.00	1.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.67	3.31	2.20	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	74.04	9.35	2.21	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	61.60	5.51	1.62	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	67.35	5.13	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	46.24	5.69	0.66	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	54.41	3.95	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	72.98	8.82	1.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	58.33	6.69	0.63	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	56.43	5.27	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	52.46	6.73	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	48.79	7.22	1.11	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	69.52	3.48	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	64.11	5.05	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	46.50	6.35	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.15	5.42	1.63	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	58.99	4.06	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	57.90	5.04	1.75	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	45.62	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	52.24	3.96	1.45	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.38	4.64	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	67.86	7.12	3.05	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	141.33	17.12	3.38	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	76.58	10.17	1.69	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	104.34	13.71	2.25	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	78.23	5.63	2.82	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	79.96	8.48	1.98	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	81.63	8.30	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	86.62	14.85	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	117.20	11.60	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	158.84	16.04	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	10.43	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	99.60	7.49	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	143.31	7.41	5.35	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	102.63	5.87	5.59	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	105.57	8.50	4.58	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	95.63	10.07	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	110.37	6.68	4.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	103.60	6.45	3.74	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	87.70	8.35	8.35	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	110.53	5.15	5.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	84.65	8.88	2.07	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	132.14	10.16	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	131.30	11.18	2.90	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	125.88	10.36	2.99	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	93.80	9.61	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	92.90	5.87	5.22	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	64.88	8.69	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	112.11	8.86	3.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	139.33	15.75	3.42	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	89.45	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	97.67	6.13	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	94.75	6.64	5.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	86.98	9.16	3.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	98.51	9.97	3.99	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	113.97	9.37	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	107.42	9.44	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	84.02	7.58	3.50	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	90.41	6.58	2.63	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	72.90	7.63	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	76.41	3.58	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	75.21	8.73	1.46	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	34.24	3.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.36	2.91	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	55.50	3.17	1.27	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	40.52	2.92	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	54.54	5.11	1.16	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.95	3.21	1.35	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	53.24	3.41	0.91	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	52.14	5.47	1.53	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	46.21	4.08	1.29	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.33	4.95	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.97	3.49	0.75	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	46.49	3.95	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	35.88	2.24	2.56	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.09	0.87	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	185.07	10.58	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.64	1.41	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	71.16	6.47	2.27	0.17
Hepatocyte, donor1	11523-119I2	78.69	3.63	3.63	0.00
Hepatocyte, donor2	11603-120I1	106.66	6.46	2.15	0.00
Hepatocyte, donor3	11684-122I1	109.21	6.75	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	87.46	9.14	3.26	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	93.16	6.12	2.10	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	62.98	7.68	1.51	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	9.55	6.37	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	52.61	5.54	5.54	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	2.50	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	0.00	7.69	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	18.28	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	47.11	4.87	6.50	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	41.68	3.33	3.33	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	71.47	3.97	2.65	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	55.43	5.54	3.33	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	5.24	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	47.87	8.82	3.15	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	7.73	3.09	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	42.64	3.23	5.81	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	8.05	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	52.97	1.63	8.15	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.46	4.20	3.36	3.36
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	64.29	6.43	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	43.39	1.85	7.39	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	60.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	32.57	3.30	3.78	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	50.79	5.44	4.53	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	1.08	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	7.62	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	40.17	6.38	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	32.81	3.65	5.47	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	45.70	2.86	5.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	13.27	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	44.14	3.40	3.40	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	43.90	5.27	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	46.59	8.34	2.09	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	9.73	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	1.74	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	2.25	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	3.48	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	38.40	2.13	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	31.87	6.93	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	5.70	2.85	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	2.76	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	16.92	2.11	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	64.46	6.45	1.31	0.16
Keratinocyte - epidermal, donor2	11349-117G8	21.08	2.34	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	58.69	3.50	2.08	0.09
Keratinocyte - oral, donor1	11251-116E9	95.70	7.61	4.54	0.23
Keratocytes, donor1	11527-119I6	17.19	1.72	0.69	0.00
Keratocytes, donor2	11607-120I5	12.89	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	47.23	5.93	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	92.31	19.78	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	81.98	9.71	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	75.89	7.61	1.73	0.35
Lens Epithelial Cells, donor3	11690-122I7	34.21	5.35	0.91	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	58.46	4.27	0.83	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.09	1.40	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	55.57	3.31	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	48.39	4.30	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.06	1.26	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.43	1.73	0.54	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.12	3.69	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.38	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	32.09	2.67	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	59.33	2.37	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	45.76	2.52	1.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.48	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	55.40	2.79	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.35	0.48	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.02	1.79	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	51.12	2.16	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.21	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	23.79	1.83	0.73	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	49.70	2.63	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.67	0.88	1.17	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.41	0.75	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.38	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	34.20	3.23	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.41	3.94	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	44.58	0.52	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	38.74	4.19	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	32.48	2.86	0.60	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	55.03	4.13	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	40.08	1.51	1.51	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.11	2.12	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.13	2.91	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	29.44	2.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.90	1.36	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	85.89	3.33	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	30.89	2.47	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.86	1.37	0.69	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	57.57	3.86	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.17	2.43	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	48.01	4.48	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	56.89	2.13	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.25	0.78	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	38.32	1.79	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	31.36	0.65	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	17.89	0.94	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	53.09	3.59	2.10	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.16	1.02	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.26	2.69	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	6.90	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	2.97	4.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.93	2.96	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	4.92	2.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	4.67	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	47.92	5.67	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	5.95	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	38.23	5.20	1.36	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.66	5.23	2.04	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.26	6.30	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	50.40	6.23	3.52	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	47.76	3.59	1.54	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.05	3.18	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	40.64	2.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.98	6.62	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.62	5.34	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	59.90	5.29	2.46	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.24	4.29	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	4.89	4.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.52	5.62	0.83	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	57.73	9.81	1.96	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	53.71	2.32	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	46.33	5.38	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	42.05	2.21	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	53.73	4.24	2.47	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	47.94	4.06	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	41.45	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	49.89	4.61	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	56.61	2.83	2.83	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.95	4.10	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	35.70	1.81	2.71	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	47.40	4.31	2.87	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	3.73	2.24	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	44.22	3.72	2.97	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.06	6.46	0.86	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.11	5.99	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.64	4.00	1.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	47.06	2.41	1.81	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.28	2.84	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	41.59	4.81	1.72	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	45.09	2.15	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	3.37	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	53.71	8.52	2.59	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	53.49	2.33	3.49	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	1.06	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	45.22	4.80	2.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	51.61	2.18	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	46.76	6.90	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	4.44	2.47	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	36.70	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	37.21	2.01	1.01	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.96	3.60	3.60	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	44.75	3.44	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.98	4.90	2.23	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	44.97	3.52	2.35	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	47.50	3.96	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	49.82	4.15	3.63	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	56.01	3.06	4.38	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.20	5.59	1.68	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.72	3.53	3.09	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.30	4.63	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	45.07	3.04	0.51	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.89	4.81	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.87	6.76	2.39	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.69	2.43	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	43.58	3.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.08	4.18	1.90	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.78	6.20	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.60	1.81	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.07	4.12	1.27	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.78	4.80	2.67	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	48.27	4.60	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	41.14	5.66	3.09	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	49.51	3.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	44.26	3.40	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	43.27	4.58	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	49.33	8.61	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	4.59	2.09	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	48.32	6.04	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	48.84	6.69	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.03	5.88	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	46.07	6.06	1.21	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	3.67	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	39.12	2.67	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	60.41	3.99	2.28	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.18	4.60	0.77	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	41.04	2.74	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	45.44	3.56	1.34	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	43.93	3.38	1.56	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	4.64	1.99	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	4.16	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	62.22	5.24	1.14	0.00
Macrophage - monocyte derived, donor2	11313-117C8	51.38	2.94	2.02	0.00
Macrophage - monocyte derived, donor3	11389-118C3	41.81	3.67	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	6.37	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	67.98	4.44	1.27	0.48
Mallassez-derived cells, donor3	11930-125I4	82.42	4.31	1.95	0.28
Mammary Epithelial Cell, donor1	11273-116H4	57.89	7.97	1.89	0.30
Mammary Epithelial Cell, donor2	11350-117G9	70.07	4.05	2.61	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.46	2.24	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	292.19	34.57	0.68	0.00
Mast cell, donor1	11563-120D6	90.95	11.46	0.87	0.11
Mast cell, donor2	11565-120D8	62.70	6.84	1.19	0.89
Mast cell, donor3	11566-120D9	104.01	11.71	2.70	0.45
Mast cell, donor4	11567-120E1	72.33	9.40	1.24	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	137.73	12.53	2.77	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	164.01	13.42	3.50	0.00
Mast cell, expanded, donor5	11939-126A4	101.99	9.06	2.18	0.11
Mast cell, expanded, donor8	11941-126A6	101.26	8.03	1.34	0.67
Melanocyte - dark, donor1	11502-119F8	49.25	4.28	0.99	0.10
Melanocyte - dark, donor2	11582-120F7	58.49	2.77	1.73	0.00
Melanocyte - dark, donor3	11663-122F7	73.96	7.90	2.83	0.07
Melanocyte - light, donor1	11274-116H5	22.57	1.88	0.47	0.24
Melanocyte - light, donor2	11351-117H1	14.33	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	15.61	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	56.23	5.10	1.77	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	56.48	4.30	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	81.16	4.82	2.14	0.27
Meningeal Cells, donor1	11493-119E8	35.98	3.35	1.24	0.00
Meningeal Cells, donor2	11573-120E7	31.69	1.76	1.32	0.00
Meningeal Cells, donor3	11654-122E7	114.84	10.43	2.85	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	73.86	7.98	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	47.80	6.74	1.91	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	44.49	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	52.73	5.51	1.91	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	3.02	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.60	1.32	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.07	1.23	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	66.07	6.09	2.63	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.90	1.86	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	92.23	9.08	4.21	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	0.89	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	86.84	5.67	2.48	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	64.11	5.94	2.81	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	43.54	2.18	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	74.51	7.69	1.59	0.27
Mesothelial Cells, donor2	12156-128G5	43.54	2.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	59.91	5.85	1.01	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	60.58	3.45	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	41.52	3.24	1.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	62.30	3.72	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.45	1.45	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.80	2.50	2.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	37.24	0.93	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.55	1.22	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.45	2.38	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.47	1.52	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	34.17	1.70	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.19	2.68	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	28.60	1.51	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.71	1.43	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.20	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	34.31	1.84	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.50	2.10	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.35	2.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	40.98	3.43	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	26.23	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.97	3.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	41.31	3.26	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	25.00	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	31.72	1.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	39.62	2.40	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	52.11	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	45.54	2.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	54.29	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	46.15	1.71	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	38.35	2.13	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	48.25	2.81	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	33.79	1.81	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	34.23	2.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	63.73	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	42.68	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.60	1.52	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	34.21	2.59	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.88	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.22	1.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.02	1.80	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.18	0.99	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	40.45	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.81	2.43	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.00	1.99	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	42.77	2.46	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	27.37	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	49.10	1.76	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	47.86	2.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	79.13	4.95	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.88	1.49	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	61.11	0.66	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	56.14	1.78	0.99	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.98	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.44	5.26	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.36	1.86	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	58.93	2.04	1.70	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	40.67	1.10	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	51.84	2.67	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.48	1.26	1.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	50.39	0.00	1.36	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	0.64	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	24.30	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	11.42	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	9.79	0.00	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	43.73	6.03	1.94	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	39.20	6.27	3.14	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	29.37	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	2.92	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	91.27	11.22	3.23	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	82.98	14.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	4.08	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	202.14	16.54	5.51	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	2.51	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.66	7.67	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.89	4.05	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	61.39	7.57	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	389.72	111.35	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.86	4.47	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	42.22	4.87	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	31.51	5.44	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	30.54	5.72	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	66.71	5.29	2.19	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	43.50	2.65	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	2.40	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	98.78	11.49	4.59	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	24.56	3.58	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	54.50	5.12	1.76	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	3.52	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	32.18	6.44	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	32.78	3.86	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	98.64	11.04	2.41	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	171.93	35.40	10.11	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.89	6.24	2.23	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.45	5.93	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	43.20	8.07	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	29.62	2.15	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	451.39	36.11	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	5.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	43.28	1.80	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.17	3.97	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	31.57	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.97	7.57	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.83	4.56	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.61	2.18	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.85	7.24	2.26	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	30.87	4.41	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	29.25	3.99	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.27	5.46	1.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	18.38	2.30	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	45.37	7.26	1.51	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	61.22	5.08	1.77	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.17	6.78	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	219.71	35.77	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	37.80	5.49	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.63	4.41	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.76	2.72	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	37.97	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	104.30	28.34	5.67	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	298.42	40.46	25.29	0.00
Myoblast, donor1	11241-116D8	53.17	7.21	1.12	0.00
Myoblast, donor2	11322-117D8	61.76	4.41	1.53	0.38
Myoblast, donor3	11398-118D3	50.62	5.55	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	68.44	4.67	1.31	1.17
Natural Killer Cells, donor1	11230-116C6	97.18	7.07	0.62	4.00
Natural Killer Cells, donor2	11311-117C6	93.78	7.84	1.81	3.62
Natural Killer Cells, donor3	11387-118C1	80.98	8.10	1.47	2.94
Neural stem cells, donor1	11275-116H6	153.52	19.60	4.72	0.00
Neural stem cells, donor2	11352-117H2	184.86	34.66	5.78	0.00
Neurons, donor1	11494-119E9	174.10	20.48	4.55	0.00
Neurons, donor2	11574-120E8	142.23	17.83	2.42	0.22
Neurons, donor3	11655-122E8	155.39	35.35	1.64	0.82
Neutrophils, donor1	11233-116C9	69.60	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	43.48	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	76.97	1.83	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	78.37	9.14	5.22	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	46.89	3.26	1.95	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	51.54	6.02	1.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	35.79	5.64	1.38	0.00
Olfactory epithelial cells, donor2	11934-125I8	57.17	6.22	1.45	0.14
Olfactory epithelial cells, donor3	11935-125I9	41.32	3.06	0.91	0.00
Olfactory epithelial cells, donor4	11936-126A1	54.83	6.04	1.95	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	68.61	4.81	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	24.46	3.62	1.49	0.43
Osteoblast - differentiated, donor2	11353-117H3	4.57	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.62	3.10	1.24	0.00
Osteoblast, donor1	11277-116H8	27.95	2.93	2.15	0.20
Osteoblast, donor2	11354-117H4	82.87	9.83	2.11	0.00
Osteoblast, donor3	11426-118G4	29.68	3.91	1.24	0.71
Pancreatic stromal cells, donor1	11249-116E7	78.68	7.24	3.96	0.34
Pericytes, donor1	11491-119E6	7.45	0.78	0.67	0.11
Pericytes, donor2	11571-120E5	9.05	1.81	0.00	0.23
Pericytes, donor3	11652-122E5	15.26	1.83	0.41	0.00
Perineurial Cells, donor1	11499-119F5	61.26	6.56	3.28	0.23
Perineurial Cells, donor2	11579-120F4	70.30	7.36	2.39	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	101.68	13.71	3.19	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	72.97	5.88	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	65.35	4.40	1.29	0.13
Placental Epithelial Cells, donor1	11278-116H9	27.98	1.67	1.20	0.48
Placental Epithelial Cells, donor2	11355-117H5	33.27	0.00	3.33	1.11
Placental Epithelial Cells, donor3	11427-118G5	15.12	2.75	1.18	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.87	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	44.27	4.88	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	82.36	8.09	2.87	0.39
Preadipocyte - breast, donor2	11328-117E5	33.10	4.73	1.13	0.23
Preadipocyte - omental, donor1	11468-119C1	49.12	6.71	1.70	0.00
Preadipocyte - omental, donor2	11329-117E6	58.05	5.67	2.18	0.00
Preadipocyte - omental, donor3	11403-118D8	35.10	5.59	0.86	0.00
Preadipocyte - perirenal, donor1	11469-119C2	15.75	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.50	3.38	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	77.56	4.96	1.95	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	42.74	3.24	0.85	0.00
Preadipocyte - visceral, donor1	11280-116I2	79.27	8.85	2.24	0.28
Preadipocyte - visceral, donor2	11357-117H7	82.83	5.52	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	54.96	4.91	0.42	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	93.08	10.86	2.11	0.30
Prostate Epithelial Cells, donor2	11331-117E8	39.13	2.57	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	37.23	3.18	1.22	0.18
Prostate Stromal Cells, donor1	11254-116F3	77.00	6.49	1.94	0.11
Prostate Stromal Cells, donor2	11332-117E9	58.27	4.30	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	37.96	4.90	0.94	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	1.46	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	78.11	4.99	1.94	0.07
Renal Epithelial Cells, donor1	11517-119H5	5.58	0.00	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.80	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	100.36	4.55	2.75	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	22.91	1.48	0.27	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	62.61	5.99	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.53	1.10	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.93	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.99	1.66	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.69	1.07	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.02	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.50	0.77	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	97.75	10.11	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.42	2.27	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	83.30	8.28	2.26	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	78.85	4.41	1.74	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	1.79	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	271.88	19.81	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	164.16	4.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	188.54	25.22	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	129.20	14.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	188.39	21.08	0.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	247.84	25.68	0.74	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	143.35	14.92	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	206.17	18.49	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	119.38	15.06	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	149.61	15.13	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	140.31	14.87	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	124.23	13.48	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	138.22	14.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	139.62	14.83	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	118.34	14.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	129.40	12.67	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	216.66	23.30	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	163.76	19.64	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	127.91	15.77	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	156.97	16.61	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	130.93	14.20	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	147.72	10.65	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	136.72	14.18	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	120.70	13.49	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	119.69	13.86	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	147.21	16.39	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	150.96	12.74	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	141.27	16.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	170.47	14.73	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	125.24	12.03	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	192.67	19.47	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	114.89	13.58	0.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	125.57	13.86	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	127.72	18.73	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	123.58	17.74	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	142.88	14.10	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	111.66	13.58	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	170.41	16.09	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	126.46	14.15	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	153.88	17.02	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	108.22	11.99	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	116.70	9.68	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	122.62	13.57	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	143.30	13.91	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	116.87	10.55	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	130.66	11.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	80.39	8.46	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	123.73	10.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	164.77	17.90	0.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	126.55	5.48	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	120.56	11.75	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	119.65	10.40	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	101.54	9.29	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	147.00	11.93	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	93.92	9.18	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.94	9.01	0.60	0.00
Schwann Cells, donor1	11498-119F4	16.17	0.75	0.38	0.00
Schwann Cells, donor2	11578-120F3	64.65	3.40	3.40	3.40
Schwann Cells, donor3	11659-122F3	64.41	3.07	1.75	0.00
Sebocyte, donor1	11220-116B5	53.68	3.29	2.19	0.55
Sebocyte, donor2	11301-117B5	30.79	3.68	0.92	0.00
Sebocyte, donor3	11378-118B1	22.47	1.86	1.44	0.00
Sertoli Cells, donor1	11255-116F4	49.70	9.94	0.00	0.00
Sertoli Cells, donor2	11333-117F1	73.43	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	55.51	7.48	2.64	0.18
Skeletal Muscle Cells, donor2	11358-117H8	11.57	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.90	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	85.93	6.44	1.26	0.16
Skeletal Muscle Cells, donor5	11455-119A6	76.11	5.80	2.82	0.15
Skeletal Muscle Cells, donor6	11459-119B1	93.26	8.31	2.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	100.30	7.69	4.66	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	66.64	3.71	3.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	70.64	6.94	1.19	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	84.84	12.47	3.62	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.73	5.50	0.96	0.14
Skin - palm, donor1	10286-104F7	56.41	10.74	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.52	1.30	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	253.55	20.45	4.09	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.67	1.04	0.39	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	60.89	5.14	1.11	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	40.37	3.24	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	138.29	14.59	3.38	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	25.78	2.47	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	21.29	1.54	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	80.26	6.89	3.11	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	5.88	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.31	2.21	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.56	4.33	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	61.05	8.01	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.41	2.93	0.80	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.90	5.54	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	53.26	6.66	1.79	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	57.63	6.19	2.28	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	68.52	5.32	2.07	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.59	3.84	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.18	0.49	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	47.49	4.26	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.83	2.27	1.52	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	1.91	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	62.82	6.78	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	58.98	4.30	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	62.24	4.72	1.05	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.80	3.40	0.77	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	19.40	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	41.24	2.99	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.97	0.68	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	84.58	5.65	4.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.67	7.65	1.31	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	37.55	1.37	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.76	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	103.59	12.98	3.18	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	63.38	7.32	1.60	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	59.98	6.14	1.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.42	2.28	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	64.08	7.69	1.06	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	2.25	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	31.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.97	0.93	3.26	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	32.82	4.04	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.64	3.45	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	1.18	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	71.64	6.41	1.75	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.24	2.80	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.16	3.17	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	30.59	2.55	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.72	3.57	0.94	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	86.78	9.78	2.10	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	62.92	7.04	1.93	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.52	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.88	1.22	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	60.10	12.81	0.88	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.32	6.14	1.46	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.29	3.89	1.75	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.81	3.70	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	84.43	7.81	1.12	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	58.21	3.23	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	54.51	4.83	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	86.65	4.33	3.15	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	52.57	5.08	3.05	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	40.33	2.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	2.93	3.76	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	47.21	4.13	0.00	0.92
Synoviocyte, donor1	11291-117A4	38.21	4.21	1.01	0.00
Synoviocyte, donor2	11368-117I9	34.03	2.85	1.17	0.00
Synoviocyte, donor3	11440-118H9	33.73	2.46	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	17.87	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.52	0.93	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	43.73	3.30	1.29	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	0.77	1.55	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	2.29	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	77.14	3.81	1.60	0.25
Urethra, donor2	10319-105A4	44.96	16.19	1.80	0.00
Urothelial Cells, donor1	11520-119H8	7.44	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	4.01	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.11	0.92	0.00	0.00
Urothelial cells, donor0	11216-116B1	60.18	5.13	1.11	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	164.61	8.01	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	172.98	8.58	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	73.93	4.11	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	131.19	8.26	3.79	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	153.39	8.72	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	147.86	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	173.46	7.34	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	78.51	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	100.17	12.46	1.60	0.12
Wilms' tumor cell line:HFWT	10597-108E3	77.44	7.92	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	96.09	10.89	1.96	0.56
achilles tendon, donor2	10292-104G4	43.40	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	118.55	9.43	3.06	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	123.52	19.50	5.57	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	144.82	13.18	3.92	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	160.28	16.60	5.44	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	81.23	4.50	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	115.26	8.04	5.71	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	195.45	9.26	2.18	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	232.66	12.78	8.37	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	115.16	6.13	4.49	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	109.50	10.87	1.16	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	91.82	5.70	2.76	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	393.95	23.40	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	136.87	10.22	5.81	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	306.02	13.98	6.73	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	215.68	10.23	5.26	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	70.18	3.25	3.72	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	92.94	5.76	2.47	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.34	2.15	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	106.68	11.52	3.84	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	88.56	10.01	3.03	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	102.30	9.15	4.33	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	94.22	6.01	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	76.72	5.34	3.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	98.48	7.43	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	138.23	9.79	10.17	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	84.17	14.83	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	18.74	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	85.49	6.83	2.35	0.24
adipose tissue, adult, pool1	10010-101C1	59.57	5.12	0.93	0.00
adipose, donor1	10184-103D4	241.60	23.46	6.45	0.59
adipose, donor2	10185-103D5	60.42	8.11	0.41	0.00
adipose, donor3	10186-103D6	88.22	16.34	1.91	0.00
adipose, donor4	10187-103D7	66.74	9.53	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	89.96	20.99	3.16	0.63
adrenal gland, adult, pool1	10081-102A9	21.83	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	61.50	5.07	2.40	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	73.96	7.86	2.14	0.00
amniotic membrane cells, donor1	12235-129G3	59.12	9.51	1.39	0.23
amniotic membrane cells, donor2	12236-129G4	64.92	9.80	3.04	0.34
amniotic membrane cells, donor3	12237-129G5	55.09	10.90	2.36	0.59
amygdala - adult, donor10196	10167-103B5	119.77	20.16	2.37	0.00
amygdala, adult, donor10252	10151-102I7	110.10	20.28	2.03	0.20
amygdala, newborn, donor10223	10360-105E9	69.07	11.62	3.55	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	77.03	8.53	1.78	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	74.57	7.94	2.87	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	140.30	27.73	1.00	0.00
aorta, adult, pool1	10052-101G7	43.54	5.88	1.37	0.00
appendix, adult	10189-103D9	135.45	8.15	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	128.98	11.69	2.75	0.69
artery, adult	10190-103E1	73.37	5.43	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	354.35	29.84	7.68	0.58
b cell line:RPMI1788	10427-106D4	84.61	8.48	2.53	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.78	6.10	1.66	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	67.68	7.44	1.69	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	67.12	4.35	0.50	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	62.08	2.24	2.24	0.00
bladder, adult, pool1	10011-101C2	54.32	8.04	2.50	0.00
blood, adult, pool1	10053-101G8	46.51	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	30.83	2.57	0.00	0.00
bone marrow, adult	10192-103E3	79.63	8.77	0.00	0.67
brain, adult, donor1	10084-102B3	48.18	11.28	3.08	0.00
brain, adult, pool1	10012-101C3	66.15	17.71	3.79	0.11
brain, fetal, pool1	10085-102B4	98.84	13.36	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	83.91	9.58	1.65	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	71.52	8.99	3.00	0.37
breast, adult, donor1	10080-102A8	28.41	2.53	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	65.93	8.13	1.40	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	107.61	13.61	1.86	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	157.24	14.27	2.76	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	61.97	7.99	1.69	0.24
carcinoid cell line:NCI-H1770	10703-109H1	98.27	11.75	3.76	0.47
carcinoid cell line:NCI-H727	10735-110B6	33.03	2.84	0.22	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	135.63	11.73	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	144.53	11.98	2.13	0.53
caudate nucleus - adult, donor10196	10177-103C6	97.86	19.57	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	74.63	11.88	2.68	0.00
caudate nucleus, adult, donor10258	10379-105H1	65.72	9.93	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	109.14	11.35	1.83	0.73
cerebellum - adult, donor10196	10173-103C2	209.76	43.70	23.31	0.00
cerebellum, adult, donor10252	10166-103B4	215.22	29.46	4.91	0.00
cerebellum, adult, pool1	10083-102B2	83.82	19.66	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	162.74	28.23	3.32	0.00
cerebral meninges, adult	10188-103D8	76.90	13.62	2.27	0.25
cerebrospinal fluid, donor2	10294-104G6	34.35	6.58	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	64.27	9.20	3.02	0.43
cervical cancer cell line:ME-180	10553-107I4	55.02	4.64	1.33	0.33
cervix, adult, pool1	10013-101C4	70.55	11.65	3.25	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.86	6.97	0.98	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	7.84	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	62.88	7.33	1.74	0.37
choriocarcinoma cell line:SCH	10785-110H2	70.97	7.89	2.71	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	56.21	4.51	0.95	0.24
chorionic membrane cells, donor1	12238-129G6	48.44	7.12	2.56	0.57
chorionic membrane cells, donor2	12239-129G7	65.03	6.86	2.19	0.20
chorionic membrane cells, donor3	12240-129G8	74.18	4.40	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	81.79	5.05	5.05	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	95.28	8.64	1.15	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.85	6.12	1.90	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	103.49	10.53	8.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	112.47	8.95	8.22	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	115.45	7.94	7.13	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	141.34	15.02	5.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	176.44	10.69	7.04	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	54.40	4.11	2.06	0.23
clear cell carcinoma cell line:TEN	10636-108I6	88.66	6.25	2.08	0.35
colon carcinoma cell line:CACO-2	10513-107D9	94.82	11.90	5.31	0.37
colon carcinoma cell line:COLO-320	10420-106C6	198.02	18.24	14.06	0.38
colon, adult, donor1	10082-102B1	64.26	4.76	1.19	0.00
colon, adult, pool1	10014-101C5	63.69	6.58	2.70	0.24
colon, fetal, donor1	10070-101I7	108.77	8.03	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	119.17	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	152.98	17.00	3.82	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	133.42	11.77	2.26	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	146.79	12.55	2.82	0.00
corpus callosum, adult, pool1	10042-101F6	65.12	17.36	3.76	0.22
cruciate ligament, donor2	10295-104G7	69.70	7.29	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	50.56	16.05	1.61	0.00
diencephalon, adult	10193-103E4	83.04	12.00	1.68	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	153.38	11.71	6.43	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	91.55	5.13	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.83	9.63	1.69	0.24
ductus deferens, adult	10196-103E7	74.75	9.47	2.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	97.94	11.52	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	133.89	12.51	2.94	0.00
dura mater, adult, donor1	10041-101F5	66.81	11.98	3.30	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	30.65	1.55	0.67	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	90.56	9.17	1.86	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	61.66	14.80	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	90.51	15.44	2.42	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	82.44	9.57	2.78	0.00
embryonic pancreas cell line:2C6	10603-108E9	93.26	14.45	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	84.47	12.40	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	86.99	12.51	4.89	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	84.43	6.11	2.41	0.00
epidermoid carcinoma cell line:A431	10426-106D3	87.48	6.11	2.11	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.57	5.06	1.21	0.66
epididymis, adult	10197-103E8	61.75	10.47	1.67	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.95	5.32	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.39	3.54	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	96.71	8.13	1.05	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	76.87	5.71	1.57	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	86.82	8.96	1.12	0.56
esophagus, adult, pool1	10015-101C6	55.64	4.25	3.29	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.29	15.53	1.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	125.56	38.63	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	77.86	21.04	0.00	0.00
eye - muscle medial, donor2	10299-104H2	56.55	14.88	1.49	0.00
eye - muscle superior, donor2	10297-104G9	64.20	5.73	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	63.30	13.98	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	72.19	7.44	3.33	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	74.79	5.94	2.14	0.24
frontal lobe, adult, pool1	10040-101F4	74.50	22.61	6.10	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	179.55	16.21	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	75.07	9.60	0.91	0.00
gall bladder, adult	10198-103E9	47.08	5.07	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	174.48	12.35	3.76	0.00
gamma delta positive T cells, donor2	11938-126A3	140.81	11.95	2.99	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	59.56	7.60	2.32	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	36.75	4.06	2.13	0.58
gastric cancer cell line:AZ521	10549-107H9	102.31	12.30	5.90	0.49
gastric cancer cell line:GSS	10560-108A2	68.64	4.58	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.53	13.02	1.83	0.00
giant cell carcinoma cell line:LU65	10487-107B1	89.15	10.56	4.25	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	55.14	6.72	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	74.08	6.48	1.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	71.46	11.51	2.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	71.76	13.62	2.11	0.14
glioblastoma cell line:T98G	10485-107A8	66.00	7.95	3.09	0.11
glioma cell line:GI-1	10413-106B8	70.88	8.20	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	61.96	12.39	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	125.22	17.33	2.93	0.00
globus pallidus, adult, donor10258	10367-105F7	95.84	16.43	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	55.96	5.86	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	124.80	22.02	12.24	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	59.20	6.40	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	92.74	7.80	6.89	0.92
hIPS +CCl2, biol_rep2	14384-156C1	109.29	7.77	3.20	0.91
hIPS +CCl2, biol_rep3	14385-156C2	88.24	3.22	5.80	0.00
hIPS, biol_rep1	14380-156B6	130.79	1.44	1.44	1.44
hIPS, biol_rep2	14381-156B7	85.73	4.12	1.37	0.00
hIPS, biol_rep3	14382-156B8	86.07	11.03	5.52	0.00
hairy cell leukemia cell line:Mo	10712-109I1	101.72	8.05	2.59	1.15
heart - mitral valve, adult	10205-103F7	70.56	12.56	3.29	0.00
heart - pulmonic valve, adult	10206-103F8	68.25	10.20	4.18	0.26
heart - tricuspid valve, adult	10207-103F9	87.43	4.16	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	66.11	9.18	2.86	0.41
heart, adult, diseased, donor1	10051-101G6	123.49	14.48	7.24	0.00
heart, adult, pool1	10016-101C7	61.17	11.50	1.84	0.00
heart, fetal, pool1	10046-101G1	114.59	14.68	2.67	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	46.28	6.17	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	73.73	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	102.98	8.51	2.76	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	120.89	10.92	2.91	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	125.00	11.22	2.63	0.81
hepatoma cell line:Li-7	10484-107A7	70.51	7.90	0.67	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	90.45	6.83	2.51	1.01
hippocampus - adult, donor10196	10169-103B7	111.67	27.44	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	102.66	17.96	1.84	0.41
hippocampus, adult, donor10258	10374-105G5	85.15	8.96	7.47	0.00
hippocampus, newborn, donor10223	10363-105F3	79.66	13.39	1.76	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	220.94	18.31	9.16	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	105.84	6.28	2.95	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	101.05	6.35	3.05	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	86.84	6.20	3.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	134.01	12.39	1.55	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	109.33	8.73	2.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	117.95	15.18	1.75	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	107.93	14.43	2.59	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	118.45	13.35	2.50	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	121.00	19.18	4.26	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	106.88	13.02	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	107.06	17.51	3.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	89.51	7.82	3.91	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	125.28	7.37	3.44	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	176.30	11.35	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	113.40	13.94	2.86	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	101.61	8.72	2.62	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	174.92	11.49	2.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	76.49	10.55	2.45	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	91.85	12.28	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	78.94	11.59	2.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	101.41	10.94	1.96	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	98.71	10.16	2.90	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	81.01	11.06	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	101.98	6.84	2.22	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	73.60	6.28	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	134.33	11.84	3.27	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	126.40	14.08	3.52	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	83.30	8.24	1.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	92.90	7.57	1.51	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	82.74	9.83	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	78.37	8.63	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	73.88	7.44	3.08	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	104.05	15.08	3.58	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	103.74	16.66	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	87.71	16.13	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	85.25	10.14	2.90	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	102.06	8.02	5.35	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	95.12	5.37	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	103.60	10.39	2.14	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1044.29	84.58	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	164.81	13.90	2.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	103.99	18.06	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	81.06	9.41	2.53	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	82.21	9.96	2.85	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	136.05	13.13	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	137.32	19.37	2.71	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	78.39	9.43	1.89	0.00
immature langerhans cells, donor1	11904-125F5	111.39	10.65	1.45	0.48
immature langerhans cells, donor2	11905-125F6	60.20	5.54	3.17	0.00
insula, adult, pool1	10039-101F3	78.36	19.59	6.06	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	52.02	7.15	2.60	0.00
kidney, adult, pool1	10017-101C8	66.89	7.71	2.10	0.10
kidney, fetal, pool1	10045-101F9	45.77	6.01	2.26	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	109.78	12.78	1.56	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.63	5.81	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.97	3.85	0.55	0.37
left atrium, adult, donor1	10079-102A7	78.46	11.44	2.18	0.00
left ventricle, adult, donor1	10078-102A6	82.93	10.11	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	73.05	10.67	1.37	1.09
leiomyoma cell line:10964C	10569-108B2	44.55	6.11	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	53.26	4.89	1.09	0.00
leiomyoma cell line:15425	10571-108B4	54.39	5.58	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	75.28	8.36	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	114.52	8.03	1.42	0.24
liposarcoma cell line:KMLS-1	10782-110G8	68.89	8.28	1.09	0.16
liposarcoma cell line:SW 872	10726-110A6	54.22	8.04	1.71	0.00
liver, adult, pool1	10018-101C9	45.05	2.76	1.46	0.32
liver, fetal, pool1	10086-102B5	32.92	3.76	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	88.08	17.21	1.02	0.15
locus coeruleus, adult, donor10252	10165-103B3	102.79	13.29	2.21	0.00
locus coeruleus, adult, donor10258	10375-105G6	58.40	14.67	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	125.34	14.72	3.36	0.84
lung adenocarcinoma cell line:A549	10499-107C4	34.60	3.18	2.35	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	4.83	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	68.94	7.38	1.32	0.00
lung, adult, pool1	10019-101D1	40.75	2.72	0.83	0.00
lung, fetal, donor1	10068-101I5	135.00	8.85	2.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	66.90	5.50	0.92	0.00
lymph node, adult, donor1	10077-102A5	58.70	6.63	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	102.58	8.55	1.75	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	207.22	21.43	3.77	1.96
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	62.86	14.44	0.85	0.00
mature adipocyte, donor1	12231-129F8	68.37	10.66	2.66	0.44
mature adipocyte, donor2	12232-129F9	59.98	8.30	3.32	0.42
mature adipocyte, donor3	12233-129G1	56.42	10.90	3.08	0.71
mature adipocyte, donor4	12234-129G2	58.70	8.69	2.90	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	92.68	20.49	2.38	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	107.16	37.23	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	119.72	21.15	1.84	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	73.39	14.93	2.54	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	196.18	37.96	5.12	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	126.23	23.12	2.87	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	129.03	18.89	4.46	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	86.68	7.71	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	732.03	172.24	86.12	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	68.56	12.92	3.59	1.08
medulla oblongata - adult, donor10196	10174-103C3	71.39	18.17	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	95.67	17.18	2.32	0.31
medulla oblongata, adult, pool1	10038-101F2	52.40	16.49	3.10	0.16
medulla oblongata, newborn, donor10223	10361-105F1	75.34	8.33	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	138.16	19.93	3.32	0.44
medulloblastoma cell line:ONS-76	10759-110E3	37.42	4.28	1.83	0.49
melanoma cell line:COLO 679	10514-107E1	75.47	7.91	1.72	0.43
melanoma cell line:G-361	10465-106H6	70.85	11.94	2.99	0.00
meningioma cell line:HKBMM	10691-109F7	59.34	2.53	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	218.53	18.50	10.57	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	239.26	29.81	4.93	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	74.42	5.83	1.99	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	48.35	5.45	2.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	64.19	2.90	2.90	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.04	4.21	1.97	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	50.84	3.08	1.16	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	44.42	4.16	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	51.32	3.60	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.65	4.60	2.30	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	56.77	5.17	1.19	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	70.63	5.27	2.16	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	76.11	6.54	1.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	51.71	5.60	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	60.05	5.26	0.83	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	63.53	2.79	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	41.85	5.31	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.74	3.95	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	56.17	7.03	1.03	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	52.67	5.24	2.51	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	122.93	10.49	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	42.74	4.93	0.75	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	73.18	7.18	1.05	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	61.48	2.95	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	46.07	4.86	1.72	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	103.15	6.74	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.97	3.20	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	42.97	3.84	1.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	39.53	6.54	3.40	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.36	1.23	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	47.78	4.00	1.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	44.68	3.38	2.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.58	3.54	1.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	35.68	2.78	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	60.28	4.90	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.70	3.35	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	50.23	2.88	2.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	48.40	0.73	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.59	2.69	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	35.21	4.91	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	2.15	2.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.43	4.55	1.30	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	2.91	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	4.26	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	1.64	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.49	3.50	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	29.80	0.99	2.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	39.73	2.37	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	4.87	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	41.17	1.27	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	43.46	5.52	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.56	3.26	2.04	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.98	2.38	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.24	2.36	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	34.60	2.18	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	3.55	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	5.14	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	27.54	3.44	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	63.34	1.98	3.96	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	46.43	3.82	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	57.63	4.03	2.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	6.54	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	44.35	6.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	6.07	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	4.52	9.04	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	41.07	4.96	1.39	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.69	4.87	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	3.06	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	43.33	1.55	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	58.59	14.41	1.18	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	120.47	21.78	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	70.38	4.21	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	54.70	6.81	1.36	0.23
mesothelioma cell line:Mero-41	10851-111F5	66.01	7.33	1.22	0.00
mesothelioma cell line:Mero-48a	10852-111F6	39.41	5.09	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	81.47	5.52	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	89.37	6.47	1.36	1.02
mesothelioma cell line:Mero-84	10855-111F9	41.71	2.53	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	81.37	4.35	1.45	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	65.93	6.63	1.82	0.33
mesothelioma cell line:NCI-H226	10846-111E9	91.22	4.89	1.63	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	64.40	3.59	1.54	0.00
mesothelioma cell line:NCI-H28	10845-111E8	63.87	8.40	2.54	0.00
mesothelioma cell line:No36	10857-111G2	48.93	2.94	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	68.01	4.06	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	109.20	8.06	2.88	0.00
migratory langerhans cells, donor2	11902-125F3	131.15	7.33	2.56	0.12
migratory langerhans cells, donor3	11903-125F4	131.74	9.15	3.95	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	54.52	5.22	1.31	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	39.42	5.93	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	37.55	3.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.37	6.66	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	137.30	8.87	5.36	0.55
myeloma cell line:PCM6	10474-106I6	95.28	10.08	2.97	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	55.80	6.59	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	41.78	3.14	1.57	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.32	3.79	1.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	51.55	5.66	1.69	0.07
nasal epithelial cells, donor2	12227-129F4	33.12	5.52	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	133.44	33.82	8.28	0.92
neuroblastoma cell line:NB-1	10539-107G8	178.85	29.56	4.30	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	91.10	9.70	1.27	0.42
neuroblastoma cell line:NH-12	10555-107I6	140.51	19.19	2.98	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	85.88	9.25	2.14	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	101.21	12.67	0.63	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	77.28	8.86	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	66.76	9.54	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	61.48	5.32	0.53	0.00
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	267.04	15.90	13.36	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	93.66	16.01	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.22	8.98	1.60	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.98	1.58	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	70.30	18.84	3.47	0.28
occipital cortex - adult, donor10196	10172-103C1	156.59	39.15	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	125.86	19.05	3.49	0.27
occipital cortex, newborn, donor10223	10355-105E4	93.17	13.47	5.10	1.09
occipital lobe, adult, donor1	10076-102A4	69.27	18.89	1.84	0.26
occipital lobe, fetal, donor1	10073-102A1	163.06	35.19	2.57	0.86
occipital pole, adult, pool1	10036-101E9	41.86	11.91	3.55	0.08
olfactory region, adult	10195-103E6	86.36	12.42	1.91	0.00
optic nerve, donor1	10277-104E7	48.03	18.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.48	7.52	2.62	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	90.81	12.23	2.61	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	75.86	5.42	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	74.50	4.97	1.50	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	43.51	6.17	1.47	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	129.87	18.69	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	89.06	19.09	0.42	0.00
ovary, adult, pool1	10020-101D2	49.53	8.21	1.92	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	69.11	7.88	0.55	0.18
pancreas, adult, donor1	10049-101G4	68.67	7.53	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	89.73	5.59	1.68	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	63.71	5.45	1.19	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	74.51	3.97	2.65	0.50
paracentral gyrus, adult, pool1	10035-101E8	66.17	22.33	5.22	0.00
parietal cortex, adult, donor10258	10373-105G4	56.52	11.74	4.40	0.00
parietal lobe - adult, donor10196	10171-103B9	81.82	25.39	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	133.40	18.53	2.28	0.29
parietal lobe, adult, pool1	10034-101E7	67.59	19.56	5.20	0.09
parietal lobe, fetal, donor1	10072-101I9	202.70	46.55	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	98.70	13.83	4.11	1.87
parotid gland, adult	10199-103F1	49.95	4.32	1.85	0.00
penis, adult	10200-103F2	69.82	9.67	3.76	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	64.15	8.37	0.19	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	113.20	7.58	1.31	0.00
pineal gland - adult, donor10196	10179-103C8	85.79	16.13	4.52	0.00
pineal gland, adult, donor10252	10160-103A7	162.86	24.87	5.92	0.00
pineal gland, adult, donor10258	10377-105G8	68.35	18.19	5.64	0.00
pituitary gland - adult, donor10196	10180-103C9	151.77	21.25	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	210.56	25.54	5.21	0.00
pituitary gland, adult, donor10258	10378-105G9	84.27	11.92	4.26	0.00
placenta, adult, pool1	10021-101D3	68.37	5.27	2.69	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	80.65	7.42	1.06	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	52.14	8.40	2.18	0.31
pons, adult, pool1	10033-101E6	71.18	20.48	3.96	0.26
postcentral gyrus, adult, pool1	10032-101E5	66.78	19.18	4.97	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	77.93	10.20	3.06	0.73
prostate cancer cell line:PC-3	10439-106E7	200.92	31.04	1.63	0.00
prostate, adult, pool1	10022-101D4	50.15	6.80	2.90	0.09
putamen, adult, donor10196	10176-103C5	101.98	24.79	3.54	0.00
putamen, adult, donor10252	10152-102I8	54.90	9.80	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	77.59	6.56	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	53.15	8.94	1.93	0.00
putamen, newborn, donor10223	10365-105F5	164.18	17.24	3.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	54.70	6.40	0.00	0.58
rectum, fetal, donor1	10067-101I4	77.90	8.35	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.04	5.72	2.97	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	93.20	6.63	2.49	0.00
retina, adult, pool1	10030-101E3	61.03	13.72	2.39	0.10
retinoblastoma cell line:Y79	10475-106I7	163.42	20.78	10.91	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	71.43	8.61	1.23	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	154.38	21.37	1.12	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	41.68	4.55	0.00	1.52
salivary acinar cells, donor1	11771-123I7	52.93	6.64	1.29	0.32
salivary acinar cells, donor2	11772-123I8	49.29	7.85	2.48	0.28
salivary acinar cells, donor3	11773-123I9	35.75	4.63	0.66	0.00
salivary gland, adult, pool1	10093-102C3	74.93	9.15	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	73.94	8.01	1.94	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	65.24	10.11	2.59	0.24
seminal vesicle, adult	10201-103F3	91.00	5.29	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	119.28	10.69	2.43	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	46.30	2.52	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	64.23	5.02	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	64.74	4.16	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	50.73	5.42	1.33	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	77.93	4.77	2.19	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	94.34	28.37	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	63.33	7.08	3.36	0.36
skeletal muscle, fetal, donor1	10066-101I3	55.28	11.06	2.01	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	130.03	13.26	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	84.38	13.34	1.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	130.49	22.69	4.41	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	70.16	11.56	2.89	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	77.30	11.21	3.79	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	93.13	12.06	1.45	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	122.91	17.65	3.49	0.65
small intestine, adult, pool1	10024-101D6	89.10	6.09	3.94	0.00
small intestine, fetal, donor1	10064-101I1	74.69	7.13	1.72	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	89.76	8.72	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	58.15	8.53	2.58	0.26
somatostatinoma cell line:QGP-1	10781-110G7	62.72	8.04	3.75	0.00
spinal cord - adult, donor10196	10181-103D1	101.17	19.27	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	78.07	13.80	4.73	0.00
spinal cord, adult, donor10258	10369-105F9	86.47	10.38	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	81.11	21.34	2.44	0.00
spinal cord, newborn, donor10223	10359-105E8	125.36	13.78	2.76	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.72	4.93	0.30	0.00
spleen, adult, pool1	10025-101D7	69.38	5.40	1.54	0.11
spleen, fetal, pool1	10044-101F8	62.85	5.64	1.43	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	103.20	5.07	3.31	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	83.36	6.84	1.52	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	64.30	6.99	2.45	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	75.45	8.60	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	67.20	9.91	2.59	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	80.91	6.35	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	26.23	2.54	0.00	0.00
stomach, fetal, donor1	10062-101H8	75.83	16.02	1.07	0.00
submaxillary gland, adult	10202-103F4	55.26	9.68	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	97.62	14.54	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	72.42	13.45	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	110.23	4.24	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	138.25	21.55	3.67	0.23
temporal lobe, adult, pool1	10031-101E4	50.10	12.97	3.65	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	153.14	22.79	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	93.18	13.63	3.08	0.00
tenocyte, donor1	11763-123H8	40.50	5.24	1.75	0.35
tenocyte, donor2	11765-123I1	32.43	3.82	2.67	0.00
tenocyte, donor3	11768-123I4	40.40	4.45	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	151.60	11.90	1.70	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	88.64	8.48	1.70	0.46
teratocarcinoma cell line:PA-1	10807-111A6	95.16	10.07	2.79	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	91.15	9.14	1.40	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	97.95	9.08	3.40	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	93.14	9.60	0.98	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	186.63	13.68	4.89	0.00
testis, adult, pool1	10026-101D8	68.72	14.28	5.05	0.43
testis, adult, pool2	10096-102C6	106.91	18.95	7.67	0.45
thalamus - adult, donor10196	10168-103B6	103.77	26.50	1.10	0.00
thalamus, adult, donor10252	10154-103A1	101.43	11.72	2.19	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	103.15	3.08	4.62	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	37.06	8.89	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	135.20	18.41	1.15	0.58
throat, adult	10209-103G2	81.14	8.74	3.00	0.00
throat, fetal, donor1	10061-101H7	91.41	14.93	2.44	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	145.47	16.49	4.37	0.20
thymus, adult, pool1	10027-101D9	101.30	9.74	4.47	0.20
thymus, fetal, pool1	10043-101F7	114.40	9.04	3.12	1.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	61.83	5.19	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	65.38	6.43	1.26	0.42
thyroid, adult, pool1	10028-101E1	63.08	6.07	1.49	0.00
thyroid, fetal, donor1	10060-101H6	53.52	13.71	1.58	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	12.32	6.16	0.00
tongue, adult	10203-103F5	85.12	9.77	3.49	0.00
tongue, fetal, donor1	10059-101H5	90.64	14.58	0.39	0.00
tonsil, adult, pool1	10047-101G2	85.55	8.92	3.51	0.20
trachea, adult, pool1	10029-101E2	61.68	4.74	2.29	0.16
trachea, fetal, donor1	10058-101H4	107.71	14.23	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	59.16	4.25	2.48	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	40.32	3.75	0.71	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	98.87	13.16	3.92	0.78
tridermal teratoma cell line:HGRT	10694-109G1	68.49	11.42	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	55.02	8.13	1.27	0.17
umbilical cord, fetal, donor1	10057-101H3	58.42	12.52	0.00	0.00
uterus, adult, pool1	10100-102D1	91.97	12.63	4.10	0.17
uterus, fetal, donor1	10055-101H1	82.42	14.33	1.54	0.51
vagina, adult	10204-103F6	44.59	1.29	0.65	0.00
vein, adult	10191-103E2	50.42	3.95	1.75	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	66.76	3.20	0.00	0.53